Ivermectin COVID-19 Off-Label Promotion and Efficacy Claims Controversy

Documented

Beginning in 2020, ivermectin, an antiparasitic drug approved for specific parasitic infections, was promoted by medical practitioners and organizations as an effective COVID-19 treatment despite limited clinical evidence, leading to widespread off-label use, animal product overdoses, supply shortages, poisoning cases, regulatory warnings, and numerous retracted or discredited studies.

AI-generated from public sources and can contain errors — verify claims independently. Learn more

Medical Misinformation and Public Health2020-20212 views

Support Webspiracy

Every entry here is AI-generated research, and that costs real API calls to produce. If you've found this useful, a coffee helps keep more entries coming.

Buy me a coffee

Front Line COVID-19 Critical Care Alliance

Organization

Active 2020-present

A group of physicians and former journalists formed in April 2020 that advocated for unproven and dubious COVID-19 treatments, including hydroxychloroquine, ivermectin, vitamin C, and various drug combinations; the organization later changed its name to the Independent Medical Alliance in January 2025.

Founded in April 2020 by eight physicians and two former journalists
Led by Paul E. Marik and Pierre Kory from inception
Initially promoted Marik's discredited sepsis treatment protocol as COVID-19 treatment
In April 2020 circulated press releases promoting hydroxychloroquine, vitamin C, heparin, and other drugs

View on Wikipedia

Ivermectin COVID-19 Off-Label Promotion and Efficacy Claims Controversy

Claims and evidence(8)

Sources(6)